Identification of transmembrane domains that regulate spatial arrangements and activity of prokineticin receptor 2 dimers

Molecular and Cellular Endocrinology

Volumn 399, Issue , 2015, Pages 362-372

  Sposini, S ^a,b   Caltabiano, G ^c   Hanyaloglu, A C ^b   Miele, R ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Bioluminescence resonance energy transfer (BRET); Dimerization; G protein coupled receptor (GPCR); Molecular modeling; Prokineticin receptor 2 (PKR2); Signaling

Indexed keywords

DIMER; G PROTEIN COUPLED RECEPTOR; MEMBRANE PROTEIN; OLIGONUCLEOTIDE; PROKINETICIN RECEPTOR 2; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSMEMBRANE DOMAIN 1; TRANSMEMBRANE DOMAIN 2; TRANSMEMBRANE DOMAIN 3; TRANSMEMBRANE DOMAIN 4; TRANSMEMBRANE DOMAIN 5; TRANSMEMBRANE DOMAIN 6; TRANSMEMBRANE DOMAIN 7; UNCLASSIFIED DRUG; PROKR2 PROTEIN, HUMAN; RECEPTOR;

ANIMAL CELL; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVITY; ENZYME REGULATION; FUNGAL CELL; GENE AMPLIFICATION; GENE DELETION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MAMMAL CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSMEMBRANE DOMAIN; AMINO ACID SEQUENCE; ANIMAL; CHO CELL LINE; CRICETULUS; GENETICS; HAMSTER; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; HEK293 CELLS; HUMANS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; SEQUENCE DELETION;

EID: 84912051951     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.10.024     Document Type: Article

References (43)

1. Current Protocols in Molecular Biology 1994, Wiley, New York. F.M. Ausubel, R. Brent, R. Kingston, D. Moore, J. Seidman, J.A. Smith (Eds.).
2. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat. Rev. Neurosci 2001, 2:274-286.
3. Bouvier M., Heveker N., Jockers R., Marullo S., Milligan G. BRET analysis of GPCR oligomerization: newer does not mean better. Nat. Methods 2007, 4:3-4.
4. Chen J., Kuei C., Sutton S., Wilson S., Yu J., Kamme F., et al. Identification and pharmacological characterization of prokineticin 2β as a selective ligand for prokineticin receptor 1. Mol. Pharmacol 2005, 67:2070-2076.
5. Cheng M.Y., Bullock C.M., Li C., Lee A.G., Bermak J.C., Belluzzi J., et al. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 2002, 417:405-410.
6. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007, 318:1258-1265.
7. Cole L.W., Sidis Y., Zhang C., Quinton R., Plummer L., Pignatelli D., et al. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum. Clin. Endocrinol. Metab 2008, 93:3551-3559.
8. De A., Loening A.M., Gambhir S.S. An improved bioluminescence resonance energy transfer strategy for imaging intracellular events in single cells and living subjects. Cancer Res 2007, 67:7175-7183.
9. Dodé C., Rondard P. PROK2/PROKR2 signaling and Kallmann syndrome. Front. Endocrinol 2013, 4:19.
10. Dodé C., Teixeira L., Levilliers J., Fouveaut C., Bouchard P., Kottler M.L., et al. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet 2006, 2:e175.
11. Dowell S.J., Brown A.J. Yeast assays for G-protein-coupled receptors. Receptors Channels 2002, 8:343-352.
12. Eidne K.A., Kroeger K.M., Hanyaloglu A.C. Applications of novel resonance energy transfer techniques to study dynamic hormone receptor interactions in living cells. Trends Endocrinol. Metab 2002, 13:415-421.
13. Fenalti G., Giguere P.M., Katritch V., Huang X.-P., Thompson A.A., Cherezov V., et al. Molecular control of D-opioid receptor signalling. Nature 2014, 1-18.
14. Giannini E., Lattanzi R., Nicotra A., Campese A.F., Grazioli P., Screpanti I., et al. The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:14646-14651.
15. Huang J., Chen S., Zhang J.J., Huang X.Y. Crystal structure of oligomeric β1-adrenergic G protein-coupled receptors in ligand-free basal state. Nat. Struct. Mol. Biol 2013, 20:419-425.
16. Kaczor A.A., Selent J. Oligomerization of G protein-coupled receptors: biochemical and biophysical methods. Curr. Med. Chem 2011, 18:4606-4634.
17. LeCouter J., Kowalski J., Foster J., Hass P., Zhang Z., Dillard-Telm L., et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001, 412:877-884.
18. Lin D.C., Bullock C.M., Ehlert F.J., Chen J.L., Tian H., Zhou Q.Y. Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J. Biol. Chem 2002, 277:19276-19280.
19. Lin R., LeCouter J., Kowalski J., Ferrara N. Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells. J. Biol. Chem 2002, 277:8724-8729.
20. Manglik A., Kruse A.C., Kobilka T.S., Thian F.S., Mathiesen J.M., Sunahara R.K., et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist. Nature 2012, 485:321-326.
21. Marsango S., Bonaccorsi di Patti M.C., Barra D., Miele R. Evidence that prokineticin receptor 2 exists as a dimer in vivo. Cell. Mol. Life Sci 2011, 68:2919-2929.
22. Martí-Renom M.A., Stuart A.C., Fiser A., Sánchez R., Melo F., Sali A. Comparative protein structure modeling of genes and genomes. Annu. Rev. Biophys. Biomol. Struct 2000, 29:291-325.
23. Mercier J.F., Salahpour A., Angers S., Breit A., Bouvier M. Quantitative assessment of b1- and b2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J. Biol. Chem 2002, 47:44925-44931.
24. Miele R., Lattanzi R., Bonaccorsi di Patti M.C., Paiardini A., Negri L., Barra D. Expression of Bv8 in Pichia pastoris to identify structural features for receptor binding. Protein Expr. Purif 2010, 73:10-14.
25. Ng K.L., Li J.D., Cheng M.Y., Leslie F.M., Lee A.G., Zhou Q.Y. Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling. Science 2005, 308:1923-1927.
26. Ngan E.S., Tam P.K. Prokineticin-signaling pathway. Int. J. Biochem. Cell Biol 2008, 40:1679-1684.
27. Overton M.C., Blumer K.J. The extracellular N-terminal domain and TM domains 1 and 2 mediate oligomerization of a yeast G protein-coupled receptor. J. Biol. Chem 2002, 277:41463-41472.
28. Palczewski K. Oligomeric forms of G protein-coupled receptors (GPCRs). Trends Biochem. Sci 2010, 35:595-600.
29. Pitteloud N., Zhang C., Pignatelli D., Li J.D., Raivio T., Cole L.W., et al. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:17447-17452.
30. Rivero-Müller A., Jonas K.C., Hanyaloglu A.C., Huhtaniemi I. Di/oligomerization of GPCRs-mechanisms and functional significance. Prog. Mol. Biol. Transl. Sci 2013, 117:163-185.
31. Sarfati J., Guiochon-Mantel A., Rondard P., Arnulf I., Garcia-Piñero A., Wolczynski S., et al. A comparative phenotypic study of Kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. J. Clin. Endocrinol. Metab 2010, 95:659-669.
32. Sbai O., Monnier C., Dodé C., Pin J.P., Hardelin J.P., Rondard P. Biased signaling through G-protein-coupled PROKR2 receptors harboring missense mutations. FASEB J. 2014, 28:3734-3744.
33. Schrodinger, L., 2012. The PyMOL molecular graphics system, Version 1.5r3.
34. Shojaei F., Wu X., Zhong C., Yu L., Liang X.H., Yao J., et al. Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 2007, 450:825-831.
35. Trettel F., Di Bartolomeo S., Lauro C., Catalano M., Ciotti M.T., Limatola C. Ligand-independent CXCR2 dimerization. J. Biol. Chem 2003, 278:40980-40988.
36. White J.F., Noinaj N., Shibata Y., Love J., Kloss B., Xu F., et al. Structure of the agonist-bound neurotensin receptor. Nature 2012, 490:508-513.
37. Wise H. The roles played by highly truncated splice variants of G protein-coupled receptors. J. Mol. Signal 2012, 7:1-13.
38. Wu B., Chien E.Y., Mol C.D., Fenalti G., Liu W., Katritch V., et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010, 330:1066-1071.
39. Wu H., Wacker D., Mileni M., Katritch V., Han G.W., Vardy E., et al. Structure of the human κ-opioid receptor in complex with JDTic. Nature 2012, 485:327-332.
40. Xu J., Xu M., Brown T., Rossi G.C., Hurd Y.L., Inturrisi C.E., et al. Stabilization of the μ-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action. J. Biol. Chem 2013, 28:21211-21227.
41. Zariñán T., Perez-Solís M.A., Maya-Núñez G., Casas-González P., Conn P.M., Dias J.A., et al. Dominant negative effects of human follicle-stimulating hormone receptor expression-deficient mutants on wild-type receptor cell surface expression. Rescue of oligomerization-dependent defective receptor expression by using cognate decoys. Mol. Cell. Endocrinol 2010, 321:112-122.
42. Zhou X.T., Chen D.N., Xie Z.Q., Peng Z., Xia K.D., Liu H.D., et al. Functional analysis of the distal region of the third intracellular loop of PROKR2. Biochem. Biophys. Res. Commun 2013, 439:12-17.
43. Zhu L., Zhao Q., Wu B. Structure-based studies of chemokine receptors. Curr. Opin. Struct. Biol 2013, 23:539-546.